Back to search

United States· US:68083-563_fac898b8-b3e7-4db5-a3ff-a3ebcdca84cf

Latanoprostene Bunod Ophthalmic Solution, 0.024%

A latanoprostene bunod product containing latanoprostene bunod, registered in United States by Gland Pharma Limited. The same ATC class is registered in 2 of our 19 countries.

ATC S01EE06US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedLatanoprostene Bunod Ophthalmic Solut…ATCS01EE06REGISTER NO.US:68083-563_fac898b8…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Latanoprostene bunod is registered in 2 of 19 countries.

Countries holding a registration under ATC S01EE06 (latanoprostene bunod), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 1 of them publish a price we can compare per daily dose

Latanoprostene bunod · ATC S01EE06

2 / 19 countries

  • Canada
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
LATANOPROSTENE BUNOD
Manufacturer
Gland Pharma Limited
Country
United States (US)
ATC code
S01EE06
ATC class
Latanoprostene bunod
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    68083-563-01
  • ndc11
    6808356301
    1 BOTTLE in 1 CARTON (68083-563-01) / 2.5 mL in 1 BOTTLE

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Latanoprostene bunod in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All latanoprostene bunod products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1f8d600b-bbe8-4f18-9068-56285ae1cb76
GET /v1/drugs/1f8d600b-bbe8-4f18-9068-56285ae1cb76?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "OPHTHALMIC",
  "source": "ndc",
  "strength": ".24",
  "substance": "LATANOPROSTENE BUNOD",
  "productndc": "68083-563",
  "dosage_form": "SOLUTION/ DROPS",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "ANDA217387",
  "marketing_category": "ANDA"
}

See everything about latanoprostene bunod.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.